HB 1099South Dakota
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Became law
Mar 10, 2026: Signed by the Governor on 2026-03-10 H.J. 547